Livsmed (A491000) Stock Overview

Engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. More details

A491000 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	5/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings are forecast to grow 74.71% per year

Earnings have grown 42.5% per year over the past 5 years

Risk Analysis

Volatile share price over the past 3 months compared to the KR market

A491000 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Livsmed Inc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Livsmed
Historical stock prices
Current Share Price	₩35,850.00
52 Week High	₩95,900.00
52 Week Low	₩35,750.00
Beta	0
1 Month Change	-50.76%
3 Month Change	-54.56%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-27.72%

Recent updates

Shareholder Returns

	A491000	KR Medical Equipment	KR Market
7D	-19.1%	0.2%	5.6%
1Y	n/a	-17.6%	182.9%

Return vs Industry: Insufficient data to determine how A491000 performed against the KR Medical Equipment industry.

Return vs Market: Insufficient data to determine how A491000 performed against the KR Market.

Price Volatility

Is A491000's price volatile compared to industry and market?
A491000 volatility
A491000 Average Weekly Movement	12.9%
Medical Equipment Industry Average Movement	8.4%
Market Average Movement	8.8%
10% most volatile stocks in KR Market	16.1%
10% least volatile stocks in KR Market	4.6%

Stable Share Price: A491000's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A491000's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	315	Jung Joo Lee	livsmed.com

Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Livsmed Inc Fundamentals Summary

How do Livsmed's earnings and revenue compare to its market cap?
A491000 fundamental statistics
Market cap	₩935.75b
Earnings (TTM)	-₩22.46b
Revenue (TTM)	₩51.72b

17.3x

P/S Ratio

-39.8x

P/E Ratio

Is A491000 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A491000 income statement (TTM)
Revenue	₩51.72b
Cost of Revenue	₩23.68b
Gross Profit	₩28.05b
Other Expenses	₩50.51b
Earnings	-₩22.46b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-900.02
Gross Margin	54.22%
Net Profit Margin	-43.42%
Debt/Equity Ratio	1.7%

How did A491000 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/23 18:28
End of Day Share Price	2026/06/23 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Livsmed Inc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jonghyun Park	DAOL Investment & Securities Co., Ltd.
Sang-Hun Lee	iM Securities
Choong-Hyun Kim	Mirae Asset Securities Co., Ltd.

Livsmed IncKOSDAQ:A491000 Stock Report